Vetoquinol has made changes to Zentonil®, its liver support range for dogs and cats.
New Zentonil® is the UK's FIRST palatable and divisible tablet range of S-adenosyl-methionine (SAMe) supplementation and now comes with the added benefit of choice: Zentonil® Advanced which contains pure SAMe plus silybin and Zentonil® Plus which contains pure SAMe only.
A patent pending microencapsulation technique protects the SAMe from the harmful effects of stomach acid, even when the tablet is split or chewed.
The ability to split the tablets makes administration more accurate and also makes the product more cost-effective for clients.
Vetoquinol's new Zentonil® formulations have proven SAMe bioavailability curves in a market where this particular type of data is often lacking
Simon Boulton, product manager said: "Our customers told us that they had difficulties associated with SAMe supplementation. We have listened to their comments and provided the solutions."
The new formulations will become available as wholesalers' Zentonil® stocks are depleted. If you wish to try new Zentonil® now, you can place an order for Zentonil® Advanced or Zentonil® Plus with your wholesaler.
For more information, please contact your local Vetoquinol sales representative or telephone the free practice support number - 0800 1698197.
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
Biogal Galed Labs has announced the launch of the PCRun Canine Babesia gibsoni molecular detection test kit.
Existing PCRun molecular detection test kits include one for canine Leptospira, Ehrlichia canis, Anaplasma platys, Parvovirus, Babesia canis, Leishmania, Feline Panleukopenia and Feline Mycoplasma haemofelis.
The company says that the major benefit of these tests is in having a PCR result inside 75 minutes, rather than waiting for up to a week for a result from a specialised laboratory.
For more information, see: http://www.biogal.co.il/about-biogal/pcrun
The 2022 programme will include 17 education streams, covering the veterinary and nursing care of companion animals, together with a stream covering veterinary wellness, leadership and management-related topics.
Speakers include veterinary experts and leaders from around the world, and the expected 2,000+ delegates will be able to collect 14 hours of CPD over the two days.
The VET Festival will also offer a Wellness Hub offering things like yoga, movement and mindfulness sessions alongside the lectures.
There'll be a diverse commercial exhibition, with more than 60 leading veterinary suppliers, and all delegates will also have free admission to the VETFest Live Party Night.
Noel Fitzpatrick, Clinical Chair at Fitzpatrick Referrals, who launched VET Festival in 2015, said: “The last 18 months have been tough for everyone but particularly difficult for veterinary professionals, many of whom were already suffering with challenges to their well-being and mental health because of the pressures of their work.
"VET Festival is an oasis of time during which they can relax and rejuvenate themselves; experiencing continuing professional development that is uplifting and inclusive and enjoying social activities and companionship that will replenish their souls.”
Tickets for VET Festival can be bought here: https://www.vetfestival.co.uk/delegate-info/ticket-information
Dechra Veterinary Products is warning veterinary professionals it is experiencing supply issues with Oxyglobin, Haemoglobin Glutamer-200.
Dechra has supplied Oxyglobin under an exclusive UK distributor agreement with Biopure Corporation since 2002. In 2009, the assets of Biopure Corporation were acquired by OPK Biotech, which has its headquarters in Cambridge, MA, USA. OPK Biotech is working to resume manufacture of Oxyglobin as soon as possible but it is not expected this will happen until well into 2011.
Bob Parmenter, Managing Director of Dechra Veterinary Products, said: "Unfortunately we are now out of stock of Oxyglobin and, due to the supplier's manufacturing issues, we are unlikely to receive new supplies in the immediate future. I would like to apologise to veterinary professionals for any inconvenience this will cause to their practice but unfortunately this situation is out of our control. We have written to all our Oxyglobin customers to inform them of the position and will keep in contact to advise them when the situation has changed."
Dechra is advising veterinary professionals that the Pet Blood Bank may be able to offer an alternative product, while Oxyglobin is out of stock. The Pet Blood Bank can be contacted on 01509 232 222, Monday to Friday between 0830 and 1830. The organisation offers a same day and next day delivery service, along with an advice line. Full details of products and services are available by logging on to www.petbloodbank.org
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
The BSAVA reports that two four month old puppies in The Netherlands have tested positive for rabies.
The puppies were imported into The Netherlands from Bulgaria on October 5th. Reports indicate that these puppies, which were both microchipped and travelling under the Pet Passport scheme, originated from a shelter in Bulgaria. They are still trying to trace the driver and passenger who delivered the puppies.
One puppy started showing signs of fever and paralysis on 10th October and was euthanased on 18th October, it has tested positive for rabies on both direct immunofluorescence (DIF) and polymerase chain reaction (PCR).
The second puppy was euthanased because it originated from the same litter, although it was living in a different area of the country by this time. This dog was suffering from haemorrhagic gastro-enteritis (HGE), but showed no neurological signs. However it has also tested positive for rabies on both DIF and PCR.
The BSAVA says this aspect of the case will be of particular concern to veterinary professionals in the UK because HGE is commonly seen in unvaccinated (imported) puppies. Preliminary reports do not make clear the vaccination status of these dogs.
BSAVA President, Professor Michael Day, said: "Not only does this demonstrate the need for pet owners to comply with pet travel legislation, but also for vets to be alert to the possibility of disease with any imported animal.
"Whilst we have been concerned about the issue of illegal imports and the enforcement of the current legislation, this latest incident also raises the possibility of rabies cases in dogs that appear to comply with the current pet passport regulation."
This calls into question whether veterinary staff in first opinion practice should be offered the pre-exposure rabies vaccination. The current recommendations from Public Health England are that all individuals at continuous and frequent risk of exposure to the rabies virus, as well as some groups at infrequent risk, should be offered pre-exposure rabies vaccination. Professor Day said: "Whilst veterinary professionals in companion animal practice are not currently included in this list, this might be a timely point to undertake a review based on a new risk assessment. I would be in support of practitioners who believe they are at risk having the option of the subsidised occupational vaccination."
UK veterinary surgeons are reminded that responsibility for dealing with illegal imports rests with local authorities; usually Trading Standards or Environmental Health. However, if a veterinary surgeon in practice has any suspicion of rabies or any other notifiable disease they should inform their local Animal Health Office.
VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
Virbac is running a promotion through which practices can claim a model showing the anatomy of a healthy dog ear canal on one side, and the changes associated with chronic damage on the other.
Product Manager Chris Geddes MRCVS said: "The models are about 15cm high and provide a useful visual aid to show clients the consequences if chronic ear disease is not kept under control. They can also be used to help show clients how to administer their pet's treatment correctly.
"These models will be a useful tool for practices to help improve client compliance. Also, we know that some dog owners find a course of ear treatments tricky, and either give the wrong dose or give up altogether, which is why we designed EasOtic to dispense the exact dose in one simple 'squirt', with one complete course in each bottle".
For details of how you can obtain a model for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
Dechra Veterinary Products (maker of Cardisure) has launched a new online CPD course which consists of a series of short presentations about treating congestive heart failure in dogs, developed with cardiology consultant Mike Martin.
According to the company, approximately 10% of dogs presented to first opinion practices have heart disease. The majority of cases are suffering with myxomatous mitral valve disease (MMVD) or, less commonly, dilated cardiomyopathy (DCM).
Mike said: "This is a series of short presentations with audio, that covers the common challenges, issues and questions that we all encounter in clinical practice. Aimed squarely at the very busy practitioner, this 'piece by piece' course will help you differentiate between cardiac and respiratory cases, update you on the current ACVIM guidelines on the treatment of heart failure in dogs and how best to monitor your patient in the short to long term. It's been a fun series to put together with the help of Dechra – enjoy."
Craig Sankey, Business Manager for Cardiology at Dechra said: "This series of bite-sized videos highlight the importance of diagnosing, treating and monitoring congestive heart failure in dogs in an interactive e-learning environment, topped with quizzes and drag and drops to test ones knowledge.
"Furthermore, the beauty of this format means Veterinary Professionals can dip in and out of each section depending on the area they need to build their expertise, without the pressure of completing the whole course all at once’.
The course equates to one hour CPD and can be found on the Dechra Academy: https://academy.dechra.com/learn/course/external/view/elearning/718/cardiology-piece-by-piece
More information about Cardisure can be found at www.dechra.co.uk/Cardisure
The service will be run by Dr Eloise Quince BVetMed CertAVP(SAM-F) PgCertVPS MANZCVS MRCVS and Dr Kate Allgood BVetMed CertAVP(SAM) MRCVS.
The practice says radioactive iodine therapy is the treatment of choice for hyperthyroid cats as it provides a permanent cure in up to 95% of cases.
It is administered by an iodine injection under the skin in a specialised unit by a trained vet and nurse.
The practice says a benefit of RI is that it treats ‘ectopic tissue’ that may be present outside of the thyroid gland, for example in the chest, which is not treated by surgical methods of thyroid removal.
Normal thyroid tissue is also spared, so that there is normal thyroid function post-treatment.
Though some blood tests need to be taken post-treatment, there is no need for ongoing blood samples and the monitoring of the thyroid function once successful treatment has occurred.
Elissa Norman, Clinical Director, who initially developed the idea for the iodine unit said: “The iodine unit first started as a scribble on a piece of paper and a dream of our team back in 2017 and it has taken a huge amount of dedication and effort from a large team of people to get to the point of opening in 2023.
"Radioactive iodine offers a lifetime cure for our hyperthyroid cats and we are delighted to be able to bring this service to the cats of East Anglia.”
To refer a cat patient, vets should email iodine@veterinary-hospital.co.uk.
Colin graduated from the RVC in 1992 and has worked as a clinical veterinary surgeon in a variety of first opinion practices and referral centres. He trained as a veterinary anaesthetist at Bristol and Cambridge Universities before moving into the pharmaceutical industry, gaining experience in drug development and technical support, and pre- and post-marketing, at a number of companies.
Colin said: “Animalcare is introducing a number of new and innovative medicines, such as Daxocox, its weekly NSAID to reduce breakthrough pain in dogs with osteoarthritis, to the veterinary sector. This makes it an exciting environment in which to provide technical support.
“I’m looking forward to exploring how my experience can be most useful in supporting Animalcare’s expansion and, more importantly, ensuring that the company’s customers receive the guidance and advice they need to optimise the effectiveness of Animalcare’s product range in treating their patients.”
For technical support, email: technical@animalcare.co.uk
Merial has announced that a recent change of licence means you can now administer the new generation NSAID, Previcox® for the relief of post operative pain associated with soft tissue and orthopaedic surgery in dogs.
Mark Riggs MRCVS, Veterinary Technical Advisor for Merial said: "Previcox (firocoxib) is now licensed for the relief of post operative pain. Oral PREVICOX can be administered starting 2 hours prior to surgery and has a rapid onset of action reaching peak plasma levels within 90 minutes. The palatable tablet can be given without food and is a realistic option which should be seriously considered when choosing pain relief for surgical patients.
"Containing the active ingredient firocoxib, Previcox is also highly COX-2 selective, being 380 times more selective for COX-2 than COX-1. As a result, it offers a highly desirable efficacy and safety profile which is particularly beneficial in cases which have gone through the additional stress of surgery.
"The recently published study by John P. Punke et al strengthens the evidence reinforcing the benefits offered by firocoxib. The research evaluated the in-vivo effects of firocoxib, meloxicam and tepoxalin in target tissues of dogs suffering with chronic osteoarthritis.
"Eight dogs were used in the cross-over study and each dog received each of the treatments (and a placebo) for seven days, with an appropriate wash out period in between. Firocoxib significantly reduced inflammatory mediators within blood and synovial fluid at all time points, whereas meloxicam only showed a significant reduction compared to baseline values at day four.
"With evidence demonstrating the speed of the anti-inflammatory effect of firocoxib, it may be time for vets to reconsider their post operative pain management. Previcox can be administered orally prior to surgery and can be given once daily for up to three days post operatively. For orthopaedic surgery this treatment schedule can be extended after the first 3 days upon judgement of the attending vet."
For further information please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
Dogs Trust, the UK's largest dog welfare charity, has teamed up with leading cardiac rehabilitation experts at Harefield Hospital to help patients in their final phase of coronary recovery.
The recovery programme, Hounds Help Hearts, is, according to the charity, a UK first and encourages post coronary patients to walk dogs as part of their recovery.
The Cardiac Rehabilitation team at Harefield Hospital aims to improve the physical, social and psychological well being of people after a heart attack or similar cardiac event. Among the recommendations for an ongoing healthy lifestyle, patients are being introduced to Dogs Trust Harefield where they can help staff, canine residents and themselves by walking some of the 150 dogs in their care. The charity hopes that heart hospitals UK wide will follow suit.
Hounds Help Hearts is part of a wider initiative to promote The Dog Prescription - a research document that highlights the ways dogs can improve human health. Dogs Trust is urging GPs all over the UK to prescribe a daily dose of dog with The Dog Prescription after research highlights the health benefits of dog ownership for both children and adults.
Lynda Evans, senior nurse /modern matron at Royal Brompton & Harefield NHS Foundation Trust, said: "Walking is one of the best forms of exercise for patients recovering from a cardiac event and what better way to do it than alongside a grateful canine companion. We have been running the 'Care For Your Heart' Rehabilitation Programme for more than 20 years and as a leading specialist heart and lung hospital we are always looking for new ways to help patients to enjoy the best possible quality of life when they return home. We are delighted to be working with Dogs Trust on this initiative and partnering patients with dogs to help them reach their full potential through interaction and physical exercise."
The Dog Prescription highlights the mental and physical benefits of dog ownership and interaction and names dog ownership as an aid to the recovery of post coronary patients
Clarissa Baldwin, Dogs Trust CEO said: "We undertook this research as we were aware of the health benefits of dog ownership but wanted to fully evaluate its potential. Amongst its ten points (which are not exhaustive), the prescription details health benefits including the fact that dogs can aid the recovery of post coronary patients. We want to spread the word about the health benefits of dogs and we hope that GPs and hospitals will start to encourage patients to engage with dogs for a healthier and happier lifestyle"
You can read the full research here.
The Veterinary Benevolent Fund (VBF) has announced the retirement of its President Dr. Lydia Brown, who had served the maximum of nine years as a trustee and member of the VBF Board.
Lydia became a director of the VBF following the merger of the Fund with the Vet Helpline (VHL) and the Veterinary Surgeons' Health Support Programme (VSHSP) in January 2005.
A past-president of the Royal College of Veterinary Surgeons (RCVS) and former chairman of the RCVS Trust, Lydia was a driving force behind the establishment of the VSHSP in 1999. This support programme was developed in response to the genuine need for a confidential service to treat veterinary surgeons with a wide variety of addictive conditions. Since then she has been involved in the expansion of the Helpline service from a telephone service to an increasingly-widely used email service.
The charity says that it is as a result of Lydia's thoroughness, sympathy and understanding, that very many veterinary surgeons and veterinary nurses have been helped to recover from many forms of addictive conditions and health problems.
The Petplan/Panasonic Monitoring Kit, which was launched last year, allows pet owners and veterinary staff to check on their animals via an app on their smartphone or tablet.
Petplan says is it being used by some veterinary practices to help provide additional security and monitoring capability within the practice.
The kit includes an indoor camera, which comes with an in-built temperature sensor and night vision, a door sensor and Smart Plug which can be remotely activated to turn on a radio, lamp, portable heater or fan to help keep animals content.
The kit also contains an SD card which allows clients to save and share video footage of their pet in its home environment with their veterinary surgeon, and practices to record and share footage with their staff or clients.
Isabella Von Mesterhazy, Head of Marketing at Petplan, said "For Petplan, keeping pets healthy always has been and always will be our priority. We worry about our pets when we are not with them and the pet Monitoring Kit addresses this problem by providing welcome reassurance that they are safe and well. We are delighted to be able to share this exclusive, time limited offer with our customers and veterinary partners to allow them to check in on their pets, from wherever they are."
To find out more and access a discount code, veterinary staff should login to petplanvet.co.uk.
This year, in collaboration with Your Cat, the charity is looking for entries which showcase the cat-human bond with a brand new theme of ‘Cat-Human Relationships’.
The judges want to see a range of relationships in a variety of situations, locations and ages. For instance, entries can include but are not limited to: pet cats with their owners in the home, street cats with the public and cats with those who work with them eg, veterinary professionals with their patients and homing centre workers with the cats in their care.
Since its launch in 2013, the competition has collectively attracted over 15,000 entries from all over the world.
Eve Davies, who runs the competition, said: "Whilst we tend to think of our relationship with cats as that of pet and owner, cats and humans can have a huge variety of unique connections with each other and we would love to see this reflected in the entries.
"This year’s theme is quite different to previous topics – for example kittens or sleeping cats – but it has the potential to be much more rewarding. As well as receiving exceptional photos over the years, we have been sent some incredibly moving stories to accompany them and we are hoping that this year will be even better still."
Twelve winning images will be selected by the iCatCare and Your Cat Magazine judges to feature in the charity’s 2020 calendar (and other materials) which will be sold to raise funds for the charity’s work, with one crowned the overall winner and gracing the front cover.
All twelve winners will each receive a certificate, copies of the calendar and a selection of iCatCare merchandise. The overall winner will also receive £500 in prize money.
To find out more and to enter, visit: www.icatcare.org/photography-competition. The competition closes at 10 am (BST) on 1 July 2019.
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Reference
Michale Garvey (pictured) has the official title of National Property Coordinator and he will work with local surveyors to ensure that landlords have realistic expectations supported by evidence at rent reviews and lease renewals.
VLA Treasurer Nicky Paull said: "This should help speed up what are sometimes protracted and expensive negotiations to the mutual benefit of corporate tenant and landlord alike.”
Michael is a Chartered Surveyor who has worked in the commercial property sector for 35 years.
He is the Managing Director of Chandler Garvey, a Fellow of both the Royal Institution of Chartered Surveyors and the Chartered Institute of Arbitrators, as well as being an RICS Registered Valuer.
He has specialised in rent reviews and lease renewals all of his career and has been a member of the RICS Arbitrators Panel for more than 10 years.
Michael also has extensive experience of the veterinary sector, having represented owners relating to disputed rent reviews, as well as acquisitions and lettings on different types of premises.
He said: “I am delighted to have been appointed by the VLA as the National Property Coordinator, with the intention of allowing the owners of veterinary premises, to have a better understanding of the rent review and lease renewal processes and in doing so even the playing field so that better outcomes are achieved.
Richard Hillman one of the VLA’s founders said: “Negotiating with large corporate groups can sometimes feel like trying to run through treacle for small landlords.
"Having an acknowledged expert on our team should help the VLA to give much needed support to our members.”
Further information about the VLA can be obtained from Richard Stephenson vicechair@vla.org.uk
https://vla.org.uk
Does your vet practice or an individual in the team deserve to be recognised for their commitment and dedication to their job? If so, this is your last chance to nominate your practice or colleagues for the Petplan Veterinary Awards held at a glittering award ceremony at BSAVA in April.
You can nominate under four categories:
Alison Andrew, Petplan's Marketing Manager, said: "Nominating your colleagues for an award is a fantastic way of expressing your appreciation for their hard work. The veterinary profession is dedicated to animal welfare and at Petplan we believe that their invaluable care and support deserves special recognition. The 11th annual Petplan Veterinary Awards will bestow great accolades upon the stars of the industry."
Ben Jones was awarded Vet of the Year in 2009. He said: "It was a great honour to be named the 2009 Petplan Vet of the Year and it has had a really positive impact. The award has greatly increased the practice's exposure in the local and national press and we've also been able to use the award to generate our own publicity."
However Ben says the greatest impact of the award has been on his customers: "They were all delighted and I think it gave them a lot of reassurance in the service we provide. It has also generated more business with new clients saying they have come to us because of the award."
Ian Patterson, a partner at St Clair Veterinary Group in Fife, said being named the 2009 Practice of the Year has also had a tremendous impact on their practice. He said: "The award meant so much to everyone right across the practice and the team here is extremely proud of their efforts. It has also given us the opportunity to generate more business through the exposure that the practice has received since winning the award."
You can nominate online at www.petplan.co.uk/vetawards. Remember to also encourage your clients to nominate your team for the contribution you have made to their pets wellbeing.
The RCVS Disciplinary Committee has accepted an application for restoration to the RCVS Register by Gordon Lonsdale, who had been struck off in March 2004 for illegally delegating acts of veterinary surgery to insufficiently qualified members of his practice staff.
At the initial Inquiry, Mr Lonsdale, who formerly worked as a sole practitioner in Shropshire, had admitted three separate charges of serious professional misconduct. These included allegations that he had instructed nurses and support staff to undertake dental extractions, dog and cat castrations, the removal of tumours or masses, the induction and maintenance of anaesthesia, lancing abscesses and suturing wounds.
At yesterday's hearing, the onus was on Mr Lonsdale to satisfy the Committee that he was fit to be restored to the Register, not least in view of his former health problems and the eight-year period for which he had been off the Register.
He provided the Committee with evidence of undertaking continuing professional development, including 130 hours of online courses and seven weeks of seeing practice, letters of endorsement from former clients and testimonials from friends and former colleagues.
The Committee accepted Mr Lonsdale's evidence that he had successfully addressed his alcoholism, which it recognised as being a contributory factor to his poor decision making in an isolated working environment. He assured the Committee of his intention that, should his application be successful, he intended to work only in a multi-handed, rather than single-handed, practice in future.
The Committee found him to be an honest and frank witness who had made a credible attempt to refresh his small animal practice knowledge; it was satisfied that he accepted the findings of the original hearing and that he had put the welfare of animals at risk, and it noted his expression of remorse.
In considering Mr Lonsdale's application, the Committee made a number of recommendations, including that he should register for the RCVS Professional Development Phase, undertake certain parts of the RCVS Certificate in Advanced Veterinary Practice, restrict himself to his recognised areas of competence, investigate communication courses run by the Veterinary Defence Society and continue with the mentoring programme provided by the Veterinary Surgeons Health Support Programme. Mr Lonsdale stated that he was willing to follow all of these recommendations.
Professor Peter Lees, who chaired and spoke on behalf of the Disciplinary Committee, concluded: "In these circumstances, we do not consider that any further period of erasure would be of benefit either to the public or the veterinary profession. Therefore, we direct the Registrar to restore Mr Lonsdale's name to the Register."
The event, which was cancelled last year because of the Covid-19 pandemic, is the first opportunity for the profession to get back together after the past two turbulent years. To mark BEVA’s 60th Birthday, special celebrations are in the pipeline as well as the 13th International Equine Colic Symposium taking place during the event.
BEVA President Lucy Grieve said: "We are all so excited that BEVA Congress is back this year, albeit that it will be a little bit different. You can expect the same event we all know and love but with a few new measures in place to ensure we can all stay safe during these uncertain times. We are also offering a virtual option for those that can’t attend in person, so that no one misses out.”
Congress Committee co-chair Tim Barnett said: “My co-chair Ceri Sherlock and I have been working hard over the past few months to put together a programme that rivals anything we’ve had before. You can expect lectures, discussion and debates on a number of topics including learning from mistakes, working in teams, and a dedicated stream of nursing lectures.”
This year Lucy has selected teamwork as the theme for BEVA Congress 2021, in celebration of the Association’s 60th anniversary. She said: “In modern day veterinary medicine, no one person can satisfactorily deliver all that is required.
“Without a team approach, from vets, nurses, practice managers, farriers and paraprofessionals the potential to maximise the health and welfare of horses cannot be fulfilled.
"This year, we intend to celebrate 60 years of teamwork and how we can do far more to serve our patients as a harmonious team than if we work alone.”
Early bird tickets for BEVA Congress are available from 19th April until 16th August 2021. Tickets provide access to all three lecture halls and exhibition halls as well as the virtual congress hub. They also include a complimentary ticket to the 13th International Equine Colic Symposium.
Early bird BEVA member prices are £499 for vets and £187 for vet nurses for all 3 days (with concessions available for those in their first three years of graduation or on a lower salary). Virtual tickets are £99 for BEVA members.
BEVA has introduced a 'peace of mind' bookings policy to reassure those whose personal situation may change between booking their ticket and the event.
Full details of the BEVA Congress programme will be announced shortly. To find out more and to book your tickets visit http://www.bevacongress.org/
Zoetis has announced the introduction of Equimidine solution in a 50% larger plastic bottle.
The company says the new 15ml multi-dose presentation, now in plastic rather than glass, offers greater safety, as well as cost-saving advantages to practices.
Equimidine, containing 10mg/ml detomidine hydrochloride and methyl parahydroxybenzoate 1 mg/ml as a preservative, is a clear solution for intravenous injection. It has sedative and analgesic properties and is indicated for use either alone or in combination with butorphanol to facilitate the handling of horses for clinical examinations, minor surgical procedures and other manipulations. It can also be used with ketamine for short duration general anaesthesia for surgical procedures such as castration.
According to the company, the new 15ml plastic bottle is more cost-effective per dose than the old 10ml glass vial. It is also safer to use as the bottle is less likely to break if accidentally dropped. The multi-dose facility involves a tightly fitted rubber bung through which a sterile needle can be inserted to withdraw each dose.
Penny McCann, Equine Product Manager, Zoetis UK Ltd, said: "The new presentation provides practical benefits for vets and the larger bottle size means the product is now even more cost-effective."
For more information, speak to your Zoetis Account Manager, refer to the SPC or contact Zoetis Customer Support on 0845 3008034.